Tumor growth and volumes, monitored over 24 days post-inoculation, were significantly inhibited by both cisplatin and 102-5 anti-CLPTM1L either as individual monotherapies or as a combination (Fig. 5e, and f). Here, CLPTM1L is linked to neoplasm.